+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sandoz AG - logo

Sandoz is recognized as the global leader in biosimilars and generic antibiotics, dermatology and transplantation medicines. It also holds leading global positions in areas ranging from generic cardiovascular, central nervous system (CNS), pain and ophthalmology to oncology, respiratory and hormonal therapeutics. Its products are sold in more than 160 countries, and reach more than 500 million patients. The company was founded in 1946 and is based in Princeton, New Jersey.

The State of the Biopharmaceutical Industry 2024 Edition - Product Thumbnail Image

The State of the Biopharmaceutical Industry 2024 Edition

  • Report
  • December 2023
  • 110 Pages
  • Global
From
Drug Formulation Market Report 2025 - Product Thumbnail Image

Drug Formulation Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Diltiazem Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Diltiazem Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • January 2024
  • 107 Pages
  • Global
From
Enoxaparin Sodium Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Enoxaparin Sodium Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • February 2024
  • 87 Pages
  • Global
From
Myocardial Infarction Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Myocardial Infarction Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • February 2024
  • 95 Pages
  • Global
From
Pulmonary Arterial Hypertension Treatment Market By Drug Type, By Type, By Route of Administration: Global Opportunity Analysis and Industry Forecast, 2021-2031 - Product Thumbnail Image

Pulmonary Arterial Hypertension Treatment Market By Drug Type, By Type, By Route of Administration: Global Opportunity Analysis and Industry Forecast, 2021-2031

  • Report
  • November 2022
  • 335 Pages
  • Global
From
New Drug Approvals and Their Contract Manufacture - 2024 Edition - Product Thumbnail Image

New Drug Approvals and Their Contract Manufacture - 2024 Edition

  • Report
  • April 2024
  • 87 Pages
  • Global
From
Renin-Inhibitors Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Renin-Inhibitors Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • October 2023
  • 74 Pages
  • Global
From
The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Respiratory Edition - The Views of 121 Respiratory Conditions Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Respiratory Edition - The Views of 121 Respiratory Conditions Patient Groups

  • Report
  • October 2022
  • 58 Pages
  • Global
Cilostazol Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type - Product Thumbnail Image

Cilostazol Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • August 2023
  • 113 Pages
  • Global
From
The Corporate Reputation of Pharma in 2021 - the Patient Perspective - Rare Disease Edition - The Views of 303 Rare-Disease Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2021 - the Patient Perspective - Rare Disease Edition - The Views of 303 Rare-Disease Patient Groups

  • Report
  • October 2022
  • 58 Pages
  • Global
The Corporate Reputation of Pharma in 2021- The Patient Perspective - Autoimmune Edition - The Views of 293 Patient Groups (138 of these respondent patient groups specialised in arthritis) - Product Thumbnail Image

The Corporate Reputation of Pharma in 2021- The Patient Perspective - Autoimmune Edition - The Views of 293 Patient Groups (138 of these respondent patient groups specialised in arthritis)

  • Report
  • November 2022
  • 57 Pages
  • Global
The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Spain Edition: The Views of 154 Spanish Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Spain Edition: The Views of 154 Spanish Patient Groups

  • Report
  • September 2022
  • 559 Pages
  • Spain
The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Italy Edition: The Views of 103 Italian Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Italy Edition: The Views of 103 Italian Patient Groups

  • Report
  • September 2022
  • 59 Pages
  • Italy
The Corporate Reputation of Pharma in 2021- The Patient Perspective - Germany Edition - The Views of 151 German Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2021- The Patient Perspective - Germany Edition - The Views of 151 German Patient Groups

  • Report
  • August 2022
  • 59 Pages
  • Germany
The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Asia Edition - The Views of 300 Asian Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Asia Edition - The Views of 300 Asian Patient Groups

  • Report
  • August 2022
  • 58 Pages
  • Asia Pacific
The Corporate Reputation of Pharma in 2021- The Patient Perspective - France Edition - The Views of 109 French Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2021- The Patient Perspective - France Edition - The Views of 109 French Patient Groups

  • Report
  • July 2022
  • 60 Pages
  • France
RFID in Pharmaceuticals Market - Growth, Trends, Covid-19 Impact, And Forecasts (2022 - 2027) - Product Thumbnail Image

RFID in Pharmaceuticals Market - Growth, Trends, Covid-19 Impact, And Forecasts (2022 - 2027)

  • Report
  • August 2022
  • 120 Pages
  • Global
From
The Corporate Reputation of Pharma in 2021 - The Patient Perspective - HIV/AIDS Edition -The Views of 168 HIV/AIDS Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2021 - The Patient Perspective - HIV/AIDS Edition -The Views of 168 HIV/AIDS Patient Groups

  • Report
  • June 2022
  • 91 Pages
  • Global
Gonorrhea Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update - Product Thumbnail Image

Gonorrhea Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update

  • Report
  • October 2023
  • 207 Pages
  • Global
From
Loading Indicator